Delivery Order SPE2DB22D3301-SPE2DB25FY8TK
- Not listed
- The Defense Logistics Agency awarded a $10,974.69 delivery order to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order is...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,072.23 for Briviact 100 mg tablets (60-count) with an ultimate completion date of August 4, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical procurement system. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,793.15 delivery order on August 18, 2025, for Briviact 75 mg tablets (60-count units) through a firm fixed-price contract with an ultimate completion date of August 19, 2025. The award is non-set-aside and competitively awarded, with performance to take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,677.12 to AmerisourceBergen Drug Corp for the supply of Briviact 100 mg tablets (60-count units) on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitive, non-set-aside award employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,733.90 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60 count) on September 10, 2025, with a completion date of September 11, 2025. This firm fixed-price, competitively awarded contract represents a single-line delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count units) valued at $2,241.28 under a firm fixed price contract type. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, serving as a critical pharmaceutical supplier to federal medical...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,002.64 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Briviact 100 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 24, 2025, with performance to occur at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $5,572.14 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Briviact 100 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Briviact 100 mg tablets (60-count packages) with a ceiling value of $1,067.55. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a $8,509.97 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Briviact 100 mg, with an ultimate completion date of September 3, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8TKDelivery Order
The Defense Logistics Agency awarded a $8,376.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Briviact 25 mg tablets (60-count units) on August 1, 2025, with an ultimate completion date of August 4, 2025. The contract is unclassified as a set-aside and represents a small-value transaction typical of the company's extensive pharmaceutical supply work with DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 billion blanket contract running through December 2026 that enables global pharmaceutical support for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor serving military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company has demonstrated consistent capability to meet federal procurement requirements through open competition, with its federal contract awards reflecting firm fixed-price delivery orders ranging from minimal values to substantial transactions exceeding $45,000. The current Briviact delivery reflects the company's role as a primary pharmaceutical supplier supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems within a flexible, comprehensive contract framework designed to ensure reliable medical supply availability across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.4k | 8/1/25 |